Hims & Hers Health Inc - Class A
Price sits at 31% of its 52-week range.
Current Price
$30.56
+8.56%GoodMoat Value
$39.91
30.6% undervaluedHims & Hers Health Inc - Class A (HIMS) Financial Statements
HIMS Computed Insights
Income Statement
Balance Sheet
Cash Flow Statement
HIMS Financial Statements & Data
Hims & Hers Health Inc - Class A (HIMS) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Hims & Hers Health Inc - Class A's financial performance and position as a Consumer Defensive company.
Trailing twelve-month (TTM) revenue is $2.35B. Gross profit (TTM) is $1.73B. EBITDA is $190.84M. Earnings per share (EPS) is $0.51. The P/E ratio is 54.20. Market capitalization is $6.96B.
Free cash flow (FCF) is $57.41M. EPS growth CAGR is 1.85%. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Hims & Hers Health Inc - Class A's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.